SWTX logo

SpringWorks Therapeutics, Inc. (SWTX)

Profile

Full Name

SpringWorks Therapeutics, Inc.

Ticker

NASDAQ: SWTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

September 13, 2019

Indexes

Not included

Website

http://www.springworkstx.com

Employees

368

Key Details

Price

$46.99

Market cap

$3.54B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$191.59M(+3417.33% YoY)

Annual EPS

-$3.48(+32.43% YoY)

PE ratio

-

Next earnings date

Aug 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $46.99
    SWTX price is $46.99

    30-Day Relative Volume

    0.00
    SWTX 30-day relative volume is 0.00

    Price Performance

    Price Most recent change

    -
    SWTX price change on Jul 2, 2025 is unknown

    Price YTD change

    +30.06%
    SWTX price is up +30.06% since January 1st

    Price 1-year change

    +28.18%
    SWTX price is up +28.18% year-on-year

    Price 3-year change

    +66.22%
    SWTX price is up +66.22% over the past 3 years

    Price Range

    Price All-time high

    $96.48
    SWTX price is currently -51.30% below its historical high of $96.48

    Price 3-year low

    $18.00
    SWTX price is currently +161.06% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $3.54B
    SWTX market capitalization is $3.54 billion

    Market cap 3-year change

    +153.26%
    SWTX market capitalization is up +153.26% over the past 3 years

    Market cap All-time high

    $4.61B
    SWTX market capitalization is currently -23.20% below its historical high of $4.61 billion

    Market cap sector rank

    -
    SWTX market capitalization is unknown

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.44%
    SWTX shares outstanding is up +1.44% year-on-year

    Shares Outstanding 3-Year Change

    +52.36%
    SWTX shares outstanding is up +52.36% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.94
    SWTX beta is 0.94

    200-day SMA

    $41.29
    SWTX price is currently +13.80% above its 200-day simple moving average

    50-day SMA

    $46.26
    SWTX price is currently +1.57% above its 50-day simple moving average

    RSI

    63.68
    SWTX 14-day relative strength index is 63.68

    Volume

    0.00
    SWTX 30-day relative volume is 0.00

    ATR

    $0.05
    SWTX average true range is $0.05

    10-day Historical Volatility

    2.18%
    SWTX 10-day historical volatility is 2.18%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $191.59M
    SWTX annual revenue is $191.59 million

    Revenue Analysts estimate

    $316.43M
    SWTX annual revenue is currently -39.45% lower than the consensus analysts' forecast

    Revenue 1-year change

    +3417.33%
    SWTX annual revenue is up +3417.33% year-on-year

    Revenue Sector rank

    -
    SWTX annual revenue is unknown

    EPS

    EPS

    -$3.48
    SWTX annual earnings per share is -$3.48

    EPS Analysts estimate

    -$4.16
    SWTX annual earnings per share is currently -16.35% lower than the consensus analysts' forecast

    EPS 1-year change

    +32.43%
    SWTX annual earnings per share is up +32.43% year-on-year

    EPS Sector rank

    -
    SWTX annual earnings per share is unknown

    Profit

    Gross profit

    $179.04M
    SWTX annual gross profit is $179.04 million

    Gross margin

    93.45%
    SWTX annual gross profit margin is 93.45%

    Operating profit

    -$278.13M
    SWTX annual operating income is -$278.13 million

    Operating margin

    -145.17%
    SWTX annual operating profit margin is -145.17%

    Net income

    -$258.13M
    SWTX annual net profit is -$258.13 million

    Net margin

    -134.73%
    SWTX annual net profit margin is -134.73%

    Expenses

    Total expenses

    $469.72M
    SWTX annual total expenses is $469.72 million

    Operating expenses

    $457.17M
    SWTX annual total operating expenses is $457.17 million

    Cost of goods sold

    $12.55M
    SWTX annual cost of goods sold is $12.55 million

    Selling, general & administrative expenses

    $256.65M
    SWTX annual SGA is $256.65 million

    Depreciation and amortization

    $3.47M
    SWTX annual depreciation & amortization is $3.47 million

    Interest expense

    -
    SWTX annual interest expense value is unknown

    Income tax

    -
    SWTX annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$278.13M
    SWTX annual earnings before interest & taxes is -$278.13 million

    EBITDA

    -$274.66M
    SWTX annual EBITDA is -$274.66 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $587.28M
    SWTX annual total assets is $587.28 million

    Non current assets

    $206.81M
    SWTX annual long term assets is $206.81 million

    Current assets

    $380.46M
    SWTX annual total current assets is $380.46 million

    Cash and cash equivalents

    $69.75M
    SWTX annual cash & cash equivalents is $69.75 million

    Accounts receivable

    $46.24M
    SWTX annual accounts receivable is $46.24 million

    Inventory

    $10.21M
    SWTX annual inventory is $10.21 million

    Liabilities

    Total liabilities

    $106.17M
    SWTX annual total liabilities is $106.17 million

    Long term liabilities

    $6.18M
    SWTX annual total long term liabilities is $6.18 million

    Current liabilities

    $99.99M
    SWTX annual total current liabilities is $99.99 million

    Accounts payable

    $12.25M
    SWTX annual accounts payable is $12.25 million

    Debt

    Total debt

    $7.91M
    SWTX annual total debt is $7.91 million

    Total debt 1-year change

    +12.12%
    SWTX annual total debt is up +12.12% year-on-year

    Long term debt

    $6.18M
    SWTX annual long term debt is $6.18 million

    Short term debt

    $1.73M
    SWTX annual short term debt is $1.73 million

    Equity & Capital

    Shareholders equity

    $481.10M
    SWTX annual stockholders equity is $481.10 million

    Book value

    $481.10M
    SWTX annual book value is $481.10 million

    Retained earnings

    -$1.15B
    SWTX annual retained earnings is -$1.15 billion

    Working capital

    $280.48M
    SWTX annual working capital is $280.48 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$175.60M
    SWTX annual cash flow from operations is -$175.60 million

    Cash from operations 1-year change

    +21.18%
    SWTX annual cash flow from operations is up +21.18% year-on-year

    Cash from investing

    $64.55M
    SWTX annual cash flow from investing activities is $64.55 million

    Cash from investing 1-year change

    +85.72%
    SWTX annual cash flow from investing activities is up +85.72% year-on-year

    Cash from financing

    $4.76M
    SWTX annual cash flow from financing activities is $4.76 million

    Cash from financing 1-year change

    -98.39%
    SWTX annual cash flow from financing activities is down -98.39% year-on-year

    CAPEX

    CAPEX

    $20.70M
    SWTX annual capital expenditures is $20.70 million

    CAPEX 1-year change

    +180.31%
    SWTX annual capital expenditures is up +180.31% year-on-year

    Free Cash Flow

    Free cash flow

    -$196.30M
    SWTX annual free cash flow is -$196.30 million

    Free cash flow 1-year change

    +14.72%
    SWTX annual free cash flow is up +14.72% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    93.45%
    SWTX annual gross profit margin is 93.45%

    Operating margin

    -145.17%
    SWTX annual operating profit margin is -145.17%

    Net margin

    -134.73%
    SWTX annual net profit margin is -134.73%

    ROA & ROE

    ROA

    -39.32%
    SWTX annual return on assets is -39.32%

    ROE

    -46.62%
    SWTX annual return on equity is -46.62%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    SWTX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    SWTX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    8.48
    SWTX price to book ratio is 8.48

    PB ratio Sector rank

    -
    SWTX price to book ratio is unknown

    PS Ratio

    PS ratio

    16.11
    SWTX price to sales ratio is 16.11

    PS ratio Sector rank

    -
    SWTX price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $3.48B
    SWTX enterprise value is $3.48 billion

    Enterprise value Sector rank

    -
    SWTX enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    -13.27
    SWTX EV/EBITDA is -13.27

    EV/EBITDA Sector rank

    -
    SWTX EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.81
    SWTX annual current ratio is 3.81

    Quick ratio

    3.70
    SWTX annual quick ratio is 3.70

    Leverage

    Debt to equity

    0.00
    SWTX annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    SWTX annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    2
    SWTX piotroski f-score is 2

    Altman Z-Score

    16.59
    SWTX altman z-score is 16.59

    Analyst ratings

    Recent major analysts updates

    May 12, 25 Guggenheim
    Neutral
    Apr 30, 25 HC Wainwright & Co.
    Neutral
    Apr 29, 25 TD Cowen
    Hold
    Apr 29, 25 Guggenheim
    Neutral
    Apr 28, 25 Barclays
    Equal-Weight
    Feb 24, 25 HC Wainwright & Co.
    Buy
    Feb 21, 25 HC Wainwright & Co.
    Buy
    Feb 12, 25 Wedbush
    Outperform
    Feb 12, 25 HC Wainwright & Co.
    Buy
    Feb 12, 25 Evercore ISI Group
    Outperform

    Institutional Ownership

    Screeners with SWTX included

    Best performing stocks last 3 months
    Best performing stocks last 5 years
    Stocks below analysts price target
    Best performing stocks YTD
    Stocks above SMA 200
    • What is the ticker symbol for SpringWorks Therapeutics, Inc.?
    • Does SpringWorks Therapeutics, Inc. pay dividends?
    • What sector is SpringWorks Therapeutics, Inc. in?
    • What industry is SpringWorks Therapeutics, Inc. in?
    • What country is SpringWorks Therapeutics, Inc. based in?
    • When did SpringWorks Therapeutics, Inc. go public?
    • Is SpringWorks Therapeutics, Inc. in the S&P 500?
    • Is SpringWorks Therapeutics, Inc. in the NASDAQ 100?
    • Is SpringWorks Therapeutics, Inc. in the Dow Jones?
    • When was SpringWorks Therapeutics, Inc.'s last earnings report?
    • When does SpringWorks Therapeutics, Inc. report earnings?

    What is the ticker symbol for SpringWorks Therapeutics, Inc.?

    The ticker symbol for SpringWorks Therapeutics, Inc. is NASDAQ:SWTX

    Does SpringWorks Therapeutics, Inc. pay dividends?

    No, SpringWorks Therapeutics, Inc. does not pay dividends

    What sector is SpringWorks Therapeutics, Inc. in?

    SpringWorks Therapeutics, Inc. is in the Healthcare sector

    What industry is SpringWorks Therapeutics, Inc. in?

    SpringWorks Therapeutics, Inc. is in the Biotechnology industry

    What country is SpringWorks Therapeutics, Inc. based in?

    SpringWorks Therapeutics, Inc. is headquartered in United States

    When did SpringWorks Therapeutics, Inc. go public?

    SpringWorks Therapeutics, Inc.'s initial public offering (IPO) was on September 13, 2019

    Is SpringWorks Therapeutics, Inc. in the S&P 500?

    No, SpringWorks Therapeutics, Inc. is not included in the S&P 500 index

    Is SpringWorks Therapeutics, Inc. in the NASDAQ 100?

    No, SpringWorks Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is SpringWorks Therapeutics, Inc. in the Dow Jones?

    No, SpringWorks Therapeutics, Inc. is not included in the Dow Jones index

    When was SpringWorks Therapeutics, Inc.'s last earnings report?

    SpringWorks Therapeutics, Inc.'s most recent earnings report was on May 9, 2025

    When does SpringWorks Therapeutics, Inc. report earnings?

    The next expected earnings date for SpringWorks Therapeutics, Inc. is August 7, 2025
    On this page